Withdrawals from the pharmaceutical benefits on 1 September 2021

TLV

10 August 2021 - Faslodex is among the medicines being withdrawn from the drug benefits on 1 September 2021.

Faslodex 250 mg/5 mL solution in pre-filled syringes for injection is withdrawn from the benefits at the request of AstraZeneca. 

Generic and parallel-distributed packaging remains within the benefits.

Read TLV News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Market access , Sweden